证券记录 · 已归档季度
IQV
IQVIA Holdings Inc. · Healthcare · Medical - Diagnostics & Research
25被追踪持有人
+2Δ持有人
68.72M持有股份
$10.83B报告持仓市值
+2新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +8.7% ·
股份流向 +1.6% ·
净新建仓位 +8.0%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 393.01K | $104.01M | n/a | −2 |
| Q2 2026 | 164 | +9 | 122.10M | $23.56B | +12 | −4 |
| Q1 2026 | 159 | -11 | 122.65M | $21.04B | +3 | −15 |
| Q4 2025 | 169 | +1 | 132.77M | $29.93B | +3 | −1 |
| Q3 2025 | 26 | -1 | 77.42M | $14.69B | +1 | −3 |
| Q2 2025 | 25 | +2 | 68.72M | $10.83B | +2 | n/a |
| Q1 2025 | 20 | -1 | 30.89M | $5.44B | n/a | −1 |
| Q4 2024 | 21 | +1 | 31.11M | $6.11B | +1 | n/a |
| Q3 2024 | 19 | -1 | 19.49M | $4.61B | +1 | −2 |
| Q2 2024 | 20 | n/a | 21.58M | $4.56B | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 19.68M | n/a | $3.10B | 0.1% | n/c | 1 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (被动) | 14.16M | n/a | $2.23B | 0.0% | n/c | 1 | SEC ↗ ×21 |
| 3 | Harris Associates (Oakmark) ✦ | 11.75M | +5.2% | $1.85B | 3.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 4 | State Street Global Advisors ✦ (被动) | 7.62M | -1.3% | $1.20B | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 4.22M | -0.4% | $661.81M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 6 | Fidelity (FMR) ✦ | 2.91M | n/a | $458.05M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 7 | Norges Bank ✦ (被动) | 1.71M | -0.9% | $270.16M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 1.56M | +130.2% | $245.10M | 0.2% | ▲ Add | 5 | SEC ↗ ×7 |
| 9 | Two Sigma Investments ✦ | 1.12M | -8.9% | $176.13M | 0.3% | ▼ Trim | 5 | SEC ↗ |
| 10 | Arrowstreet Capital ✦ | 848.77K | +193.1% | $133.76M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 11 | Capital World Investors ✦ | 589.84K | 0.0% | $92.95M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | PRIMECAP Management ✦ | 543.57K | +83.1% | $85.66M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 436.68K | -55.3% | $68.82M | 0.1% | ▼ Trim | 5 | SEC ↗ ×2 |
| 14 | Marshall Wace ✦ | 350.20K | -54.9% | $55.19M | 0.1% | ▼ Trim | 5 | SEC ↗ ×2 |
| 15 | Appaloosa ✦ | 300.00K | 新增 | $47.28M | 0.7% | New | 1 | SEC ↗ |
| 16 | Millennium Management ✦ | 278.92K | -14.3% | $43.96M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 245.02K | -13.8% | $38.61M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 18 | Renaissance Technologies ✦ | 103.05K | -60.0% | $16.24M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | Glenview Capital ✦ | 100.00K | 新增 | $15.76M | 0.4% | New | 1 | SEC ↗ |
| 20 | Gotham Asset Management ✦ | 65.96K | +119.2% | $10.40M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 21 | Markel Group ✦ | 49.64K | -15.5% | $7.82M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 22 | Adage Capital Partners ✦ | 36.43K | -49.5% | $5.74M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 23 | Wellington Management ✦ | 33.62K | +3.3% | $5.30M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 24 | Fisher Asset Management ✦ | 8.95K | -55.1% | $1.41M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 25 | Citadel Advisors ✦ | 6.53K | -94.3% | $1.03M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Appaloosa | $47.28M | 0.7% |
| Glenview Capital | $15.76M | 0.4% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,061 持有人, 150.48M 股份, $24.99B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 02
Berkshire James G.
Officer · 2.67K 股 · $697,228
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据